Dr. Pectasides is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana-Farber Cancer Institute
450 Brookline Ave
Boston, MA 02215Phone+1 857-215-1230
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2010 - 2012
- University of ConnecticutInternship, Internal Medicine, 2009 - 2010
- University of AthensClass of 2006
Certifications & Licensure
- MA State Medical License 2015 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Career Development Award ASCO - Conquer Cancer Foundation
- Young Investigator Award ASCO - Conquer Cancer Foundation, 2015
- Gastric Cancer Fellowship AACR, 2015
Publications & Presentations
PubMed
- 16 citationsPhase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival.Leonie K. de Klerk, Anuj K. Patel, Sarah Derks, Eirini Pectasides, Jeremy Augustin
Journal for Immunotherapy of Cancer. 2021-09-01 - 111 citationsCirculating tumor DNA in advanced solid tumors: Clinical relevance and future directionsMichael Cheng, Eirini Pectasides, Glenn J. Hanna, Heather A. Parsons, Atish D. Choudhury
CA. 2021-03-01 - 4 citationsPrognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy.Eirini Pectasides, Ioannis Chatzidakis, Vassiliki Kotoula, Georgia-Angeliki Koliou, Kyriaki Papadopoulou
Cancer Genomics & Proteomics. 2020-05-01
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: